Accuray is a radiation therapy company that develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments. Co.'s technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, its TomoTherapy platform, are designed to deliver various treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Co. also provide services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other services. We show 58 historical shares outstanding datapoints in our coverage of ARAY's shares outstanding history.
Understanding the changing numbers of ARAY shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ARAY versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ARAY by allowing them to research ARAY shares outstanding history
as well as any other stock in our coverage universe. |
Free ARAY Email Alerts:
Video: Shares Outstanding Importance
